BG
PRCT icon

Bellevue Group’s Procept Biorobotics PRCT Stock Holding History

Bellevue Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Hold
502,286
– – 0.24% 67
2026
Q1 		$12.6M Sell
502,286
-13,144
-3% -$370K 0.3% 58
2025
Q4 		$16.2M Buy
515,430
+52,026
+11% +$1.73M 0.31% 54
2025
Q3 		$16.5M Sell
463,404
-25,874
-5% -$1.18M 0.34% 52
2025
Q2 		$28.2M Buy
489,278
+74,355
+18% +$4.2M 0.62% 42
2025
Q1 		$24.2M Sell
414,923
-47,971
-10% -$3.28M 0.54% 46
2024
Q4 		$37.3M Sell
462,894
-149,797
-24% -$12.8M 0.72% 31
2024
Q3 		$49.1M Sell
612,691
-56,358
-8% -$4M 0.8% 32
2024
Q2 		$40.9M Sell
669,049
-221,065
-25% -$13.1M 0.66% 40
2024
Q1 		$44M Buy
890,114
+4,768
+0.5% +$227K 0.67% 47
2023
Q4 		$37.1M Sell
885,346
-2,950
-0.3% -$100K 0.57% 55
2023
Q3 		$29.1M Buy
888,296
+146,779
+20% +$5M 0.47% 64
2023
Q2 		$26.2M Hold
741,517
– – 0.37% 67
2023
Q1 		$21.1M Hold
741,517
– – 0.31% 79
2022
Q4 		$30.8M Buy
741,517
+152,255
+26% +$6.54M 0.41% 68
2022
Q3 		$24.4M Sell
589,262
-6,118
-1% -$244K 0.35% 76
2022
Q2 		$19.5M Buy
595,380
+309,305
+108% +$11.3M 0.28% 87
2022
Q1 		$10M Buy
286,075
+112,426
+65% +$2.71M 0.12% 105
2021
Q4 		$4.34M Buy
173,649
+23,649
+16% +$875K 0.04% 130
2021
Q3 		$5.72M Buy
+150,000
New +$5.76M 0.06% 128

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group's PRCT Position: Q2 2026 in Review

Bellevue Group held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 502,286 shares worth $11.3M. The position accounts for 0.24% of the portfolio, ranked #67.

Bellevue Group first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $49.1M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bellevue Group held 502,286 shares of Procept Biorobotics worth $11.3M as of Q2 2026.
  • Bellevue Group left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up 0.24% of Bellevue Group's portfolio in Q2 2026, its #67 holding.
  • Bellevue Group first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
  • Bellevue Group's Procept Biorobotics position peaked at $49.1M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.